German Society bags RNA vaccines EUR 2 million E.Ü. Price vaccine
German Society bags RNA vaccines EUR 2 million E.Ü. Price vaccine - Brussels CureVac, a company based in Tübingen, Germany, which develops vaccines and RNA-based therapies, has won a prize of € 2 million granted by the European Commission to stimulate new vaccine technology that could help developing...